Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?

Assante, Gabriella; Williams, Roger; Youngson, Neil Alexander

Assante, Gabriella; Williams, Roger; Youngson, Neil Alexander.

Assante G; The Institute of Hepatology, Foundation for Liver Research, London, UK.
Williams R; The Institute of Hepatology, Foundation for Liver Research, London, UK.
Youngson NA; The Institute of Hepatology, Foundation for Liver Research, London, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK; School of medical Sciences, UNSW Sydney, Australia. Electronic address: n.youngson@researchinliver.org.uk.

J Hepatol ; 74(2): 487-488, 2021 02.

Article in English | MEDLINE | ID: covidwho-1065328

Subject(s)

COVID-19; Gastrointestinal Microbiome; Humans; Retrospective Studies; SARS-CoV-2

Keywords

COVID-19; Gut-liver axis; Inflammation; Intestinal permeability; MAFLD; Obesity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastrointestinal Microbiome / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: J.jhep.2020.05.051

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google